A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/506 (2006.01) A61K 45/00 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2671776
This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and apharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist.
Blackburn Thomas P.
Boteju Lakmal W.
Chen Heidi
Jimenez Hermo
Konkel Michael
H. Lundbeck A/s
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Gal3 receptor antagonists for the treatment of depression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gal3 receptor antagonists for the treatment of depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gal3 receptor antagonists for the treatment of depression will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1890415